Institute for International Research Clinical Trials Congress
|
| 10 – 11 February // Philadelphia
This premier industry forum is designed to help senior-level clinical operations executives build and implement a clinical strategy to compete more effectively in the marketplace and to bring drugs to market faster. BBK will exhibit and also present on the topic of "problem protocols" on day two of the conference. Using a case-study approach, BBK's leader of global operations, Matt Kibby, will provide practical, real-world guidance for identifying enrollment barriers and rescuing these difficult-to-enroll protocols. His presentation includes how to use research to select the most productive sites and target the optimal media solutions for patient outreach.
|
Health Network Communications (HNC)
Clinical Outsourcing World |
| 18 – 19 February // Amsterdam
Senior speakers from the world's leading pharmaceutical companies will address patient recruitment and retention in an interactive session at this unique conference in Amsterdam. The event is designed to help high-level directors and industry executives learn patient recruitment strategies and techniques from the most experienced professionals. BBK's Matt Kibby will be among the experts speaking at the conference on 18 February.
|
SMi Group Accelerating Patient Recruitment & Retention in Clinical Trials |
| 1 – 2 April // London
High-level executives involved in pharmaceutical research and development come together to learn the latest innovations in increasing patient recruitment and retention levels at SMi's 5th annual event in London this April. BBK Worldwide's Kate Booth will chair day one of the event, and be among the recruitment and retention experts presenting on day two. She will discuss a new breed of health consumer known as the "e-patient" – one who takes charge of finding information about their diagnosis and treatment options via the Internet. Her discussion will profile the new e-patient, offer strategies for getting his/her attention, and assess the benefits and challenges of partnering with this population to optimize clinical trial participation. BBK will also exhibit at this conference.
|